Tenascin-C Signaling in melanoma

References

• Sullivan RJ, Fisher DE. Understanding the Biology of Melanoma and Therapeutic Implications. Hematol Oncol Clin North Am 2014; 28:437-53; PMID:24880940; http://dx.doi.org/10.1016/j.hoc.2014.02.007
   PubMed Web of Science ®Google Scholar
• Elenbaas B, Weinberg RA. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res 2001; 264:169-84; PMID:11237532; http://dx.doi.org/10.1006/excr.2000.5133
   PubMed Web of Science ®Google Scholar
• Midwood KS, Orend G. The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal 2009; 3:287-310; PMID:19838819; http://dx.doi.org/10.1007/s12079-009-0075-1
   PubMed Web of Science ®Google Scholar
• Engel J. EGF-like domains in extracellular matrix proteins: localized signals for growth and differentiation? FEBS Lett 1989; 251:1-7; PMID:2666164; http://dx.doi.org/10.1016/0014-5793(89)81417-6
   PubMed Web of Science ®Google Scholar
• Aukhil I, Joshi P, Yan Y, Erickson HP. Cell- and heparin-binding domains of the hexabrachion arm identified by tenascin expression proteins. J Biol Chem 1993; 268:2542-53; PMID:7679097
   PubMed Web of Science ®Google Scholar
• Rodrigues M, Yates CC, Nuschke A, Griffith L, Wells A. The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasL. Tissue Eng Part A 2013; 19:1972-83; PMID:23541003; http://dx.doi.org/10.1089/ten.tea.2012.0568
   PubMed Web of Science ®Google Scholar
• Grahovac J, Becker D, Wells A. Melanoma cell invasiveness is promoted at least in part by the epidermal growth factor-like repeats of tenascin-C. J Invest Dermatol 2013; 133:210-20; PMID:22951722; http://dx.doi.org/10.1038/jid.2012.263
   PubMedGoogle Scholar
• Saito Y, Imazeki H, Miura S, Yoshimura T, Okutsu H, Harada Y, Ohwaki T, Nagao O, Kamiya S, Hayashi R, et al. A peptide derived from tenascin-C induces beta1 integrin activation through syndecan-4. J Biol Chem 2007; 282:34929-37; PMID:17901052; http://dx.doi.org/10.1074/jbc.M705608200
   PubMed Web of Science ®Google Scholar
• Joshi P, Chung CY, Aukhil I, Erickson HP. Endothelial cells adhere to the RGD domain and the fibrinogen-like terminal knob of tenascin. J Cell Sci 1993; 106(Pt 1):389-400; PMID:7505785
   PubMed Web of Science ®Google Scholar
• Bourdon MA, Ruoslahti E. Tenascin mediates cell attachment through an RGD-dependent receptor. J Cell Biol 1989; 108:1149-55; PMID:2466038; http://dx.doi.org/10.1083/jcb.108.3.1149
   PubMed Web of Science ®Google Scholar
• Grahovac J, Wells A. Matrikine and matricellular regulators of EGF receptor signaling on cancer cell migration and invasion. Lab Invest 2014; 94:31-40; PMID:24247562; http://dx.doi.org/10.1038/labinvest.2013.132
   PubMedGoogle Scholar
• Fowler WE, Erickson HP. Trinodular structure of fibrinogen. Confirmation by both shadowing and negative stain electron microscopy. J Mol Biol 1979; 134:241-9; PMID:537064; http://dx.doi.org/10.1016/0022-2836(79)90034-2
   PubMed Web of Science ®Google Scholar
• Hancox RA, Allen MD, Holliday DL, Edwards DR, Pennington CJ, Guttery DS, et al. Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms. Breast Cancer Res 2009; 11:R24; PMID:19405959
   PubMed Web of Science ®Google Scholar
• Kharait S, Hautaniemi S, Wu S, Iwabu A, Lauffenburger DA, Wells A. Decision tree modeling predicts effects of inhibiting contractility signaling on cell motility. BMC Syst Biol 2007; 1:9; PMID:17408516; http://dx.doi.org/10.1186/1752-0509-1-9
   PubMedGoogle Scholar
• Zaman MH, Trapani LM, Sieminski AL, Mackellar D, Gong H, Kamm RD, Wells A, Lauffenburger DA, Matsudaira P. Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proc Natl Acad Sci U S A 2006; 103:10889-94; PMID:16832052; http://dx.doi.org/10.1073/pnas.0604460103
   PubMed Web of Science ®Google Scholar
• Friedl P, Maaser K, Klein CE, Niggemann B, Krohne G, Zanker KS. Migration of highly aggressive MV3 melanoma cells in 3-dimensional collagen lattices results in local matrix reorganization and shedding of alpha2 and beta1 integrins and CD44. Cancer Res 1997; 57:2061-70; PMID:9158006
   PubMed Web of Science ®Google Scholar
• Friedl P, Sahai E, Weiss S, Yamada KM. New dimensions in cell migration. Nat Rev Mol Cell Biol 2012; 13:743-7; PMID:23072889; http://dx.doi.org/10.1038/nrm3459
   PubMed Web of Science ®Google Scholar
• Swindle CS, Tran KT, Johnson TD, Banerjee P, Mayes AM, Griffith L, Wells A. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor. J Cell Biol 2001; 154:459-68; PMID:11470832; http://dx.doi.org/10.1083/jcb.200103103
   PubMed Web of Science ®Google Scholar
• Iyer AK, Tran KT, Borysenko CW, Cascio M, Camacho CJ, Blair HC, Bahar I, Wells A. Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity. J Cell Physiol 2007; 211:748-58; PMID:17311283; http://dx.doi.org/10.1002/jcp.20986
   PubMedGoogle Scholar
• Schenk S, Hintermann E, Bilban M, Koshikawa N, Hojilla C, Khokha R, Quaranta V. Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. J Cell Biol 2003; 161:197-209; PMID:12695504; http://dx.doi.org/10.1083/jcb.200208145
   PubMed Web of Science ®Google Scholar
• Schenk S, Quaranta V. Tales from the crypt; [ic] sites of the extracellular matrix. Trends Cell Biol 2003; 13:366-75; PMID:12837607; http://dx.doi.org/10.1016/S0962-8924(03)00129-6
   PubMed Web of Science ®Google Scholar
• Iyer AK, Tran KT, Griffith L, Wells A. Cell surface restriction of EGFR by a tenascin cytotactin-encoded EGF-like repeat is preferential for motility-related signaling. J Cell Physiol 2008; 214:504-12; PMID:17708541; http://dx.doi.org/10.1002/jcp.21232
   PubMed Web of Science ®Google Scholar
• Haugh JM, Huang AC, Wiley HS, Wells A, Lauffenburger DA. Internalized epidermal growth factor receptors participate in the activation of p21(ras) in fibroblasts. J Biol Chem 1999; 274:34350-60; PMID:10567412; http://dx.doi.org/10.1074/jbc.274.48.34350
   PubMedGoogle Scholar
• Haugh JM, Schooler K, Wells A, Wiley HS, Lauffenburger DA. Effect of epidermal growth factor receptor internalization on regulation of the phospholipase C-gamma1 signaling pathway. J Biol Chem 1999; 274:8958-65; PMID:10085141; http://dx.doi.org/10.1074/jbc.274.13.8958
   PubMedGoogle Scholar
• Glading A, Uberall F, Keyse SM, Lauffenburger DA, Wells A. Membrane proximal ERK signaling is required for M-calpain activation downstream of epidermal growth factor receptor signaling. J Biol Chem 2001; 276:23341-8; PMID:11319218; http://dx.doi.org/10.1074/jbc.M008847200
   PubMed Web of Science ®Google Scholar
• Fan VH, Tamama K, Au A, Littrell R, Richardson LB, Wright JW, Wells A, Griffith LG. Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells. Stem Cells 2007; 25:1241-51; PMID:17234993; http://dx.doi.org/10.1634/stemcells.2006-0320
   PubMed Web of Science ®Google Scholar
• Tamama K, Fan VH, Griffith LG, Blair HC, Wells A. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells 2006; 24:686-95; PMID:16150920; http://dx.doi.org/10.1634/stemcells.2005-0176
   PubMed Web of Science ®Google Scholar
• Rakosy Z, Vizkeleti L, Ecsedi S, Voko Z, Begany A, Barok M, Krekk Z, Gallai M, Szentirmay Z, Adány R, et al. EGFR gene copy number alterations in primary cutaneous malignant melanomas are associated with poor prognosis. Int J Cancer 2007; 121:1729-37; PMID:17594688; http://dx.doi.org/10.1002/ijc.22928
   PubMedGoogle Scholar
• Timar J, Gyorffy B, Raso E. Gene signature of the metastatic potential of cutaneous melanoma: too much for too little? Clin Exp Metastasis 2010; 27:371-87; PMID:20177751; http://dx.doi.org/10.1007/s10585-010-9307-2
   PubMed Web of Science ®Google Scholar
• Tucker RP, Chiquet-Ehrismann R. The regulation of tenascin expression by tissue microenvironments. Biochim Biophys Acta 2009; 1793:888-92; PMID:19162090; http://dx.doi.org/10.1016/j.bbamcr.2008.12.012
   PubMed Web of Science ®Google Scholar
• Natali PG, Nicotra MR, Bartolazzi A, Mottolese M, Coscia N, Bigotti A, Zardi L. Expression and production of tenascin in benign and malignant lesions of melanocyte lineage. Int J Cancer 1990; 46:586-90; PMID:1698727; http://dx.doi.org/10.1002/ijc.2910460406
   PubMedGoogle Scholar
• Tuominen H, Kallioinen M. Increased tenascin expression in melanocytic tumors. J Cutan Pathol 1994; 21:424-9; PMID:7532653; http://dx.doi.org/10.1111/j.1600-0560.1994.tb00284.x
   PubMed Web of Science ®Google Scholar
• Brellier F, Martina E, Degen M, Heuze-Vourc'h N, Petit A, Kryza T, Courty Y, Terracciano L, Ruiz C, Chiquet-Ehrismann R. Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors. BMC Clin Pathol 2012; 12:14; PMID:22947174; http://dx.doi.org/10.1186/1472-6890-12-14
   PubMedGoogle Scholar
• Hood BL, Grahovac J, Flint MS, Sun M, Charro N, Becker D, Wells A, Conrads TP. Proteomic analysis of laser microdissected melanoma cells from skin organ cultures. J Proteome Res 2010; 9:3656-63; PMID:20459140; http://dx.doi.org/10.1021/pr100164x
   PubMedGoogle Scholar
• Hoek K, Rimm DL, Williams KR, Zhao H, Ariyan S, Lin A, Kluger HM, Berger AJ, Cheng E, Trombetta ES, et al. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res 2004; 64:5270-82; PMID:15289333; http://dx.doi.org/10.1158/0008-5472.CAN-04-0731
   PubMed Web of Science ®Google Scholar
• Kaariainen E, Nummela P, Soikkeli J, Yin M, Lukk M, Jahkola T, Virolainen S, Ora A, Ukkonen E, Saksela O, et al. Switch to an invasive growth phase in melanoma is associated with tenascin-C, fibronectin, and procollagen-I forming specific channel structures for invasion. J Pathol 2006; 210:181-91; PMID:16924594; http://dx.doi.org/10.1002/path.2045
   PubMed Web of Science ®Google Scholar
• Adam B, Toth L, Pasti G, Balazs M, Adany R. Contact stimulation of fibroblasts for tenascin production by melanoma cells. Melanoma Res 2006; 16:385-91; PMID:17013087; http://dx.doi.org/10.1097/01.cmr.0000205022.25397.86
   PubMedGoogle Scholar
• Herlyn M, Graeven U, Speicher D, Sela BA, Bennicelli JL, Kath R, Guerry D, 4th. Characterization of tenascin secreted by human melanoma cells. Cancer Res 1991; 51:4853-8; PMID:1716515
   PubMed Web of Science ®Google Scholar
• Burchardt ER, Hein R, Bosserhoff AK. Laminin, hyaluronan, tenascin-C and type VI collagen levels in sera from patients with malignant melanoma. Clin Exp Dermatol 2003; 28:515-20; PMID:12950343; http://dx.doi.org/10.1046/j.1365-2230.2003.01326.x
   PubMedGoogle Scholar
• Maschler S, Grunert S, Danielopol A, Beug H, Wirl G. Enhanced tenascin-C expression and matrix deposition during Ras/TGF-β-induced progression of mammary tumor cells. Oncogene 2004; 23:3622-33; PMID:15116096; http://dx.doi.org/10.1038/sj.onc.1207403
   PubMed Web of Science ®Google Scholar
• Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417:949-54; PMID:12068308; http://dx.doi.org/10.1038/nature00766
   PubMed Web of Science ®Google Scholar
• Goh FG, Piccinini AM, Krausgruber T, Udalova IA, Midwood KS. Transcriptional regulation of the endogenous danger signal tenascin-C: a novel autocrine loop in inflammation. J Immunol 2010; 184:2655-62; PMID:20107185; http://dx.doi.org/10.4049/jimmunol.0903359
   PubMed Web of Science ®Google Scholar
• Tran KT, Griffith L, Wells A. Extracellular matrix signaling through growth factor receptors during wound healing. Wound Repair Regen 2004; 12:262-8; PMID:15225204; http://dx.doi.org/10.1111/j.1067-1927.2004.012302.x
   PubMed Web of Science ®Google Scholar
• Wells A. Tumor invasion: role of growth factor-induced cell motility. Adv Cancer Res 2000; 78:31-101.
   Google Scholar
• Friedl P, Gilmour D. Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 2009; 10:445-57; PMID:19546857; http://dx.doi.org/10.1038/nrm2720
   PubMed Web of Science ®Google Scholar
• Gunasinghe NP, Wells A, Thompson EW, Hugo HJ. Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer. Cancer Metastasis Rev 2012; 31:469-78; PMID:22729277; http://dx.doi.org/10.1007/s10555-012-9377-5
   PubMed Web of Science ®Google Scholar
• Talts JF, Wirl G, Dictor M, Muller WJ, Fassler R. Tenascin-C modulates tumor stroma and monocyte/macrophage recruitment but not tumor growth or metastasis in a mouse strain with spontaneous mammary cancer. J Cell Sci 1999; 112 (Pt 12):1855-64; PMID:10341205
   PubMed Web of Science ®Google Scholar
• O'Connell JT, Sugimoto H, Cooke VG, MacDonald BA, Mehta AI, LeBleu VS, Dewar R, Rocha RM, Brentani RR, Resnick MB, et al. VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization. Proc Natl Acad Sci USA 2011; 108:16002-7; PMID:21911392; http://dx.doi.org/10.1073/pnas.1109493108
   PubMed Web of Science ®Google Scholar
• Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414:105-11; PMID:11689955; http://dx.doi.org/10.1038/35102167
   PubMed Web of Science ®Google Scholar
• Wicha MS. Cancer stem cells and metastasis: lethal seeds. Clin Cancer Res 2006; 12:5606-7; PMID:17020960; http://dx.doi.org/10.1158/1078-0432.CCR-06-1537
   PubMed Web of Science ®Google Scholar
• Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ. Efficient tumour formation by single human melanoma cells. Nature 2008; 456:593-8; PMID:19052619; http://dx.doi.org/10.1038/nature07567
   PubMed Web of Science ®Google Scholar
• Fukunaga-Kalabis M, Martinez G, Nguyen TK, Kim D, Santiago-Walker A, Roesch A, Herlyn M. Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side population. Oncogene 2010; 29:6115-24; PMID:20729912; http://dx.doi.org/10.1038/onc.2010.350
   PubMedGoogle Scholar
• Rodrigues M, Griffith LG, Wells A. Growth factor regulation of proliferation and survival of multipotential stromal cells. Stem Cell Res Ther 2010; 1:32; PMID:20977782; http://dx.doi.org/10.1186/scrt32
   PubMed Web of Science ®Google Scholar